Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J (2016) 1.40

Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19

Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2014) 1.02

Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet (2012) 0.87

Clinical immunology review series: an approach to desensitization. Clin Exp Immunol (2010) 0.85

A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organ J (2011) 0.81

Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res (2015) 0.79

Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy (2012) 0.78

Immunomodulatory treatments for aspirin exacerbated respiratory disease. Am J Rhinol Allergy (2012) 0.77

Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients. Clin Transl Allergy (2013) 0.76

Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review. Am J Rhinol Allergy (2012) 0.76

Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2016) 0.76

Update on the Management of Aspirin-Exacerbated Respiratory Disease. Allergy Asthma Immunol Res (2016) 0.75

No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease. Int J Med Sci (2015) 0.75

Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis. Curr Allergy Asthma Rep (2015) 0.75

Does my patient have asthma? Perm J (2011) 0.75

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 0.75

Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification of a Danish patient cohort according to EAACI/ENDA guidelines. Clin Transl Allergy (2015) 0.75

Anaphylaxis during the perioperative period. Anesth Analg (2003) 5.96

Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55

Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol (2005) 4.67

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature (2011) 4.10

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med (2011) 3.66

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med (2010) 2.98

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest (2005) 2.94

A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med (2010) 2.53

The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol (2010) 2.52

Health effects of air pollution. J Allergy Clin Immunol (2004) 2.34

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med (2010) 2.28

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med (2002) 2.14

Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc (2015) 2.09

Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood (2012) 2.08

Case records of the Massachusetts General Hospital. Case 9-2011. A 37-year-old man with flushing and hypotension. N Engl J Med (2011) 2.07

Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol (2008) 2.07

Generalized bullous eruption after routine vaccination in a child with diffuse cutaneous mastocytosis. J Allergy Clin Immunol Pract (2012) 2.01

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol (2009) 1.94

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature (2013) 1.93

Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A (2009) 1.77

Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol (2006) 1.76

The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol (2014) 1.75

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69

RNase G complementation of rne null mutation identifies functional interrelationships with RNase E in Escherichia coli. Mol Microbiol (2002) 1.66

Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med (2006) 1.63

Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J (2012) 1.58

Latex allergy: an update. Anesth Analg (2003) 1.51

Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51

Escherichia coli spotted double-strand DNA microarrays: RNA extraction, labeling, hybridization, quality control, and data management. Methods Mol Biol (2003) 1.48

Characterization of a population presenting with suspected mold-related health effects. Ann Allergy Asthma Immunol (2005) 1.48

Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol (2003) 1.47

Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med (2005) 1.45

Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. Ann Allergy Asthma Immunol (2010) 1.44

Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol (2002) 1.41

V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol (2002) 1.40

Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study. Ann Allergy Asthma Immunol (2002) 1.40

Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med (2002) 1.40

Hereditary angioedema: an instructive model of clinical description, molecular discovery, and development of new effective treatments. Allergy Asthma Proc (2011) 1.39

Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol (2011) 1.34

Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol (2007) 1.28

Anesthesia in the patient with multiple drug allergies: are all allergies the same? Curr Opin Anaesthesiol (2011) 1.28

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol (2009) 1.24

Ca(2+) homeostasis and structural and functional remodelling of airway smooth muscle in asthma. Thorax (2010) 1.22

Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema. Allergy Asthma Proc (2015) 1.19

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol (2013) 1.18

International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol (2012) 1.17

The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2002) 1.14

Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14

Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. J Immunol (2005) 1.14

T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci U S A (2011) 1.13

Allergy: the unmet need. Clin Med (2003) 1.13

Analysis of intergenic transcription in the human IL-4/IL-13 gene cluster. Proc Natl Acad Sci U S A (2004) 1.12

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12

Current and emerging management options for hereditary angioedema in the US. Drugs (2008) 1.10

The -159 C-->T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol (2003) 1.10

The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09

Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol (2011) 1.07

Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol (2006) 1.06

Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med (2007) 1.06

Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat (2011) 1.06

Aspirin-sensitive respiratory disease. Annu Rev Physiol (2009) 1.06

Climate change and our environment: the effect on respiratory and allergic disease. J Allergy Clin Immunol Pract (2013) 1.05

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J Allergy Clin Immunol (2006) 1.05

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol (2004) 1.04

The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med (2009) 1.04

Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol (2006) 1.03

A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol (2014) 1.03

Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol (2005) 1.02

Induction of angiogenesis by airway smooth muscle from patients with asthma. Am J Respir Crit Care Med (2008) 1.01

Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol (2008) 1.00

Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol (2005) 0.99

The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98

Life after transcription--revisiting the fate of messenger RNA. Trends Genet (2003) 0.98

Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97

Clues to an early diagnosis of Kallmann syndrome. Am J Med Genet A (2010) 0.97

Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol (2009) 0.97

Air pollution and allergic disease. Curr Allergy Asthma Rep (2009) 0.97

A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med (2014) 0.96

Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol (2006) 0.96

Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism. J Pediatr (2008) 0.95

Human Th2 cells selectively express the orexigenic peptide, pro-melanin-concentrating hormone. Proc Natl Acad Sci U S A (2007) 0.95

Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol (2004) 0.94

Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1. J Allergy Clin Immunol (2012) 0.94

Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. J Pediatr (2010) 0.93

Poor asthma control and exposure to traffic pollutants and obesity in older adults. Ann Allergy Asthma Immunol (2012) 0.92

Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allergy Asthma Immunol (2008) 0.92

Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92

Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes. Curr Allergy Asthma Rep (2014) 0.91

Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol (2002) 0.91

Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90

Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Rev Clin Immunol (2012) 0.90

Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol (2012) 0.90

Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc (2016) 0.90

Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol (2012) 0.89

CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders. Clin Lymphoma Myeloma (2006) 0.89